Traditional Chinese medicine compound preparation for treating primary dysmenorrhea in female menstrual period and use method of traditional Chinese medicine compound preparation
Through the coordinated treatment of traditional Chinese medicine composition A and external gel B, the complex pathogenesis of traditional Chinese medicine is solved, and the problem of transdermal administration of qi stagnation, blood stasis, kidney yang deficiency is difficult for traditional Chinese medicine to take into account, and the dual effects of rapid pain relief and periodic conditioning are achieved, the safety hazards of toxic medicinal materials are avoided, and the treatment effect is improved.
Patent Information
- Application Number
- CN202510963230.6
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2025-07-14
- Publication Date
- 2025-08-15
AI Technical Summary
There are adverse reactions to existing Western medicine drugs for treating primary dysmenorrhea. Traditional Chinese medicine prescriptions are difficult to take into account the complex pathogenesis of qi stagnation, blood stasis, and kidney yang deficiency. The bottleneck of transdermal drug delivery technology and safety hazards of toxic medicinal materials, and lack the dual effects of rapid pain relief and cyclical conditioning.
Oral capsules are made using Chinese medicine composition A (vinegaricum yamnus, angelica, salt eucommia ulmoides, rose flower, wine white peony, ginger charcoal) and combined with specific techniques to achieve coordinated treatment of internal and external treatment. Avoid toxicity through microwave vinegar and nitrogen carbonization treatment, and develop a targeted drug delivery system.
It has achieved safe and efficient dual regulation of qi and blood, rapid pain relief and cycle conditioning, significantly improved bioavailability, shortened onset time, and significantly better than traditional prescriptions.